Next |
home / stock / ocup / ocup message board
Subject | By | Source | When |
---|---|---|---|
skip | Dr_Vonschellan | investorshub | 11/29/2022 7:28:47 PM |
$OCUP CompanyOverview | conix | investorshub | 11/23/2022 4:10:05 PM |
If it wasn't for the election stuff, this | KOmani | investorshub | 11/08/2022 4:00:21 PM |
Analysts calling for 24-26$ target | PennyPusher786 | investorshub | 11/08/2022 3:19:40 PM |
This may just rise all day with that | PennyPusher786 | investorshub | 11/08/2022 3:03:10 PM |
Nice news but seems someone is shorting everything. | KOmani | investorshub | 11/08/2022 1:26:45 PM |
Still waiting for this to favorably turn | batski | investorshub | 05/13/2022 9:38:44 PM |
I guess today's news wasn't good enough :( | bcapps66 | investorshub | 03/29/2022 3:08:28 PM |
Yes I'm waiting even if it takes another | batski | investorshub | 02/18/2022 10:41:38 PM |
At this point, seems best to wait for | bcapps66 | investorshub | 01/27/2022 5:52:50 PM |
amen | batski | investorshub | 01/24/2022 3:21:39 PM |
My heart is breaking on this one :'( | bcapps66 | investorshub | 01/24/2022 2:45:39 PM |
These red days are getting rather annoying | bcapps66 | investorshub | 12/01/2021 3:02:26 PM |
And the bleeding continues :( | bcapps66 | investorshub | 11/30/2021 5:32:16 PM |
Took some call options today looking good for | Chad088 | investorshub | 11/27/2021 2:42:53 AM |
Too late to run....I'm a long term holder now | bcapps66 | investorshub | 11/24/2021 11:58:43 PM |
Aholes are making $ by letting shorts short | 420man | investorshub | 11/24/2021 11:15:22 PM |
I'm an official bagholder | bcapps66 | investorshub | 11/24/2021 10:57:42 PM |
I can literally see the CEO and cohorts | 420man | investorshub | 11/24/2021 10:04:54 PM |
DILUTION POS's selling into good news.. SO sad! | 420man | investorshub | 11/24/2021 9:08:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Ocuphire Pharma Inc Com Company Name:
OCUP Stock Symbol:
NASDAQ Market:
FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that Daniel Su, ...
LYNX-2 Follows SPA Agreement with FDA Development of PS is Funded by Ocuphire’s Partner Viatris FARMINGTON HILLS, Mich., April 11, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for t...
FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of unmet needs of patients with retinal and refractive eye disorders, today announced the U.S. comme...